|
Volumn 5, Issue 2-3, 2001, Pages 145-151
|
Sinus node dysfunction
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADRENERGIC RECEPTOR BLOCKING AGENT;
ANTIARRHYTHMIC AGENT;
ANTIHYPERTENSIVE AGENT;
ATROPINE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CARDIAC GLYCOSIDE;
CIMETIDINE;
HISTAMINE H2 RECEPTOR ANTAGONIST;
ISOPRENALINE;
LITHIUM;
OPIATE DERIVATIVE;
SEDATIVE AGENT;
XAMOTEROL;
AGED;
ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DISEASE SEVERITY;
ELECTROPHYSIOLOGY;
EPIDEMIOLOGY;
HEMODYNAMICS;
HOLTER MONITORING;
HUMAN;
INTERMETHOD COMPARISON;
MULTICENTER STUDY;
PACEMAKER;
PATHOPHYSIOLOGY;
PRIMARY PREVENTION;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
SINUS NODE DYSFUNCTION;
SYMPTOMATOLOGY;
|
EID: 0034837455
PISSN: 13852264
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1011424312828 Document Type: Article |
Times cited : (3)
|
References (50)
|